STOCK TITAN

NU SKIN ENTERPRISES (NUS) SEC Filings, May-Jun 2026

NUS NYSE

Nu Skin Enterprises, Inc. filings document the company’s operating results, governance, executive leadership changes and financing arrangements. Recent 8-K reports include quarterly and annual financial-result releases, officer appointments and resignations, compensation arrangements, and material definitive agreements tied to amended credit facilities.

The company’s proxy materials provide annual meeting governance and executive-compensation disclosures, including board and compensation matters reported under Schedule 14A. Nu Skin’s regulatory record also reflects its capital structure and liquidity arrangements, including term loan and revolving credit facilities, alongside formal disclosures for its beauty and wellness operations, affiliate platform and Rhyz-related business activities.

Rhea-AI Summary

Zorko Mark A reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. director Mark A. Zorko received a grant of 26,643 shares of Class A Common Stock on June 1, 2026 at no purchase price. Following this equity award, he directly holds 60,586 shares. This is a compensation-related grant, not an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

NU SKIN ENTERPRISES, INC. director Edwina D. Woodbury reported both a sale and a stock grant of Class A Common Stock. On June 1, 2026, she executed an open-market sale of 7,203 shares at $5.70 per share. The same day, she acquired 26,643 shares through a grant or award at no stated purchase price. Following these transactions, her direct holdings totaled 62,433 shares of Class A Common Stock. The footnote states the sale occurred under a pre-arranged trading plan intended to comply with Rule 10b5-1(c) adopted on February 19, 2026, indicating the sale’s timing was planned in advance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

NU SKIN ENTERPRISES, INC. director Emma S. Battle received a grant of Class A Common Stock as equity compensation. She acquired 26,643 shares at a stated price of $0.0000 per share, increasing her direct holdings to 57,648 shares of Class A Common Stock following the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
Rhea-AI Summary

Thomas Pisano R. reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. director Thomas R. Pisano received a grant of Class A Common Stock as equity compensation. On June 1, 2026, he was awarded 26,643 shares at no purchase price, reflecting a stock-based award rather than an open-market buy. Following this grant, he directly holds 116,827 shares of Nu Skin Class A Common Stock, indicating the transaction increased his equity stake through a routine compensation-related award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

CAMPBELL DANIEL W reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. director Daniel W. Campbell received a grant of 26,643 shares of Class A Common Stock at no cash cost, increasing his direct holdings to 65,859 shares. He also has indirect ownership of 10,010 shares through a limited liability company he and his spouse own and control, and 53,375 shares through an irrevocable family trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
other
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
other
-
Rhea-AI Summary

Nu Skin Enterprises, Inc. reported results from its 2026 Annual Meeting of Stockholders. Stockholders approved and adopted the Amended and Restated 2024 Omnibus Incentive Plan, which had previously been approved by the board and its Compensation and Human Capital Committee, subject to stockholder approval.

All nine director nominees, including Emma S. Battle and Ryan S. Napierski, were elected with over 33.5 million votes each in favor and 5,430,258 broker non-votes recorded for each seat. Stockholders gave advisory approval of the Company’s executive compensation with 33,111,458 votes for, 1,255,101 against, and 37,082 abstentions.

Approval of the Amended and Restated 2024 Omnibus Incentive Plan received 24,185,333 votes for, 10,177,825 against, and 40,483 abstentions. Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm, with 38,798,633 votes for, 970,082 against, and 65,184 abstentions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
current report
-
Rhea-AI Summary

Charles Schwab Investment Management Inc. files an Amendment to Schedule 13G reporting 4.45% ownership of Nu Skin Enterprises Class A Common Stock, representing 2,143,294 shares. The filing states sole voting and dispositive power over those 2,143,294 shares. The amendment is signed by Omar Aguilar on 05/13/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
ownership
Rhea-AI Summary

Nu Skin Enterprises director Laura Nathanson reported an open-market sale of 2,676 shares of Class A Common Stock at $6.73 per share. After this transaction, she directly holds 30,473 shares. The sale represents a relatively small portion of her reported direct holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.12%
Tags
insider

FAQ

How many NU SKIN ENTERPRISES (NUS) SEC filings are available on StockTitan?

StockTitan tracks 71 SEC filings for NU SKIN ENTERPRISES (NUS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for NU SKIN ENTERPRISES (NUS)?

The most recent SEC filing for NU SKIN ENTERPRISES (NUS) was filed on November 16, 2026.